HIV-1 Escape from Small-Molecule Antagonism of Vif

ABSTRACT The HIV-1 accessory protein Vif, which counteracts the antiviral action of the DNA-editing cytidine deaminase APOBEC3G (A3G), is an attractive and yet unexploited therapeutic target. Vif reduces the virion incorporation of A3G by targeting the restriction factor for proteasomal degradation...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mark Sharkey, Natalia Sharova, Idrees Mohammed, Sarah E. Huff, Indrasena Reddy Kummetha, Gatikrushna Singh, Tariq M. Rana, Mario Stevenson
Format: article
Langue:EN
Publié: American Society for Microbiology 2019
Sujets:
Vif
Accès en ligne:https://doaj.org/article/4d8741ca218e4772905c111bd892ffb2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!